Individualized neoadjuvant PD-1 inhibitors combined with chemotherapy for resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC): A single-center, retrospective trial
第一作者机构：[1]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Chen X.,Li Z.,Li P.,et al.Individualized neoadjuvant PD-1 inhibitors combined with chemotherapy for resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC): A single-center, retrospective trial[J].ANNALS OF ONCOLOGY.2024,35:doi:10.1016/j.annonc.2024.10.468.
APA：
Chen, X.,Li, Z.,Li, P.,Xu, H.,Yang, Z....&Ding, Y..(2024).Individualized neoadjuvant PD-1 inhibitors combined with chemotherapy for resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC): A single-center, retrospective trial.ANNALS OF ONCOLOGY,35,
MLA：
Chen, X.,et al."Individualized neoadjuvant PD-1 inhibitors combined with chemotherapy for resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC): A single-center, retrospective trial".ANNALS OF ONCOLOGY 35.(2024)
医学